Abstract: A sliding door opening and closing device that horizontally opens and closes the sliding door with application of light weight is provided. A load-type door opening and closing device includes: a sliding support rail slidably supporting the door to open and close the door; a door opening rail provided in the door and inclined upward in an opening direction of the door; a sliding member sliding on the door opening rail; a footboard; and a coupling member that couples the sliding member with the footboard. The sliding member is located at an upper end side of the door opening rail when the door is closed, and is depressed against the door opening rail by stepping force acting on the footboard during opening operation, to displace the door in the opening direction.

Abstract: A sliding door opening and closing device that horizontally opens and closes the sliding door with application of light weight is provided. A load-type door opening and closing device includes: a sliding support rail slidably supporting the door to open and close the door; a door opening rail provided in the door and inclined upward in an opening direction of the door; a sliding member sliding on the door opening rail; a footboard; and a coupling member that couples the sliding member with the footboard. The sliding member is located at an upper end side of the door opening rail when the door is closed, and is depressed against the door opening rail by stepping force acting on the footboard during opening operation, to displace the door in the opening direction.

Abstract: A vector for creating kf-1 gene knockout nonhuman animals exhibiting increased anxiety-like behaviors, and containing Lox-pM-M-kf-1[in3b]-kf-1[ex4a]-LoxP, (wherein, M is a selection marker gene, pM is a promoter for the expression of the selection marker gene, kf-1[in3b] is a sequence represented by SEQ ID NO: 2, and kf-1[ex4a] is a sequence represented by SEQ ID NO: 3); kf-1 gene knockout nonhuman animals exhibiting increased anxiety-like behaviors produced by using the vector or a descendant of the animal, and a method for use of the same.

Abstract: An ABA tri-block copolymer represented by the following formula (1) [in the formula (1), n and m are each independently an integer of 30 to 1,000]. The copolymer is a so-called ABA tri-block copolymer between 8-vinyloxytricyclo [5.2.1.02.6] decane and n-butyl vinyl ether, has rubber elasticity at normal temperature, and has a property of thermoplastic elastomer which has not been possessed by conventional vinyl ether copolymers.

Abstract: An ABA tri-block copolymer represented by the following formula (1) [in the formula (1), n and m are each independently an integer of 30 to 1,000]. The copolymer is a so-called ABA tri-block copolymer between 8-vinyloxytricyclo[5.2.1.02.6]decane and n-butyl vinyl ether, has rubber elasticity at normal temperature, and has a property of thermoplastic elastomer which has not been possessed by conventional vinyl ether copolymers.

Abstract: Disclosed is a DNA comprising a mucleotide sequence coding for the signal peptide of Bacillus brevis substantially represented by the sequence (I): ##STR1##

Abstract: Certain 2,2'-dithiobis-N-substituted or unsubstituted benzamides or derivatives thereof are useful as antithrombotic agents because of their ability to suppress aggregation of blood platelets.

Abstract: The compound of the formula ##STR1## is disclosed to have a less rapid decrease in blood pressure in its use as an antihypertensive.

Abstract: A vasodilating or anti-hypertensive composition comprises a pharmaceutical carrier and an effective amount of a 1,4-dihydropyridine compound as an active ingredient. The 1,4-dihydropyridine compound may be represented by the following general formula: ##STR1## wherein R'.sub.1 and R'.sub.4 represent a hydrogen atom, R'.sub.2 and R'.sub.3 represent an alkyl group having 1-5 carbon atoms or a substituted heterocyclic group wherein a substituent is an N-benzylpiperidyl group, R'.sub.5 represents a nitro group, and R'.sub.6 and R'.sub.7 represent an alkyl group having 1-5 carbon atoms.

Abstract: Novel dibenz [b,e] oxepin derivatives represented by the general formula: ##STR1## wherein R.sub.11 represents an alkyl group containing 1 to 5 carbon atoms, an alkoxy group containing 1 to 5 carbon atoms, a halogen atom, a cyclohexyl group or a phenyl group; and R.sub.21 represents ##STR2## wherein X represents a hydrogen atom, a hydroxy group, an amino group or a substituted aralkyl group containing 7 to 20 carbon atoms, and n represents 0 or an integer of 1 to 3 ##STR3## wherein Y represents an alkylamino group containing 1 to 5 carbon atoms, an aralkyl group containing 7 to 20 carbon atoms, a substituted aralkyl group, an aralkyloxy group containing 7 to 20 carbon atoms, an aralkylamino group containing 7 to 20 carbon atoms, a heterocyclic ring or a substituted heterocyclic ring, and n has the same meaning as defined before; provided that when R.sub.

Abstract: Novel dibenz [b,e] oxepin derivatives represented by the general formula: ##STR1## wherein R.sub.11 represents an alkyl group containing 1 to 5 carbon atoms, an alkoxy group containing 1 to 5 carbon atoms, a halogen atom, a cyclohexyl group or a phenyl group; and R.sub.21 represents ##STR2## wherein X represents a hydrogen atom, a hydroxy group, an amino group or a substituted aralkyl group containing 7 to 20 carbon atoms, and n represents 0 or an integer of 1 to 3 ##STR3## or (3) --NH--(CH.sub.2).sub.n --Y, wherein Y represents an alkylamino group containing 1 to 5 carbon atoms, an aralkyl group containing 7 to 20 carbon atoms, a substituted aralkyl group, an aralkyloxy group containing 7 to 20 carbon atoms, an aralkylamino group containing 7 to 20 carbon atoms, a heterocyclic ring or a substituted heterocyclic ring, and n has the same meaning as defined before; provided that when R.sub.